Reduced CNS exposure of memantine in a triple transgenic mouse model of Alzheimer's disease assessed using a novel LC-MS technique

- A memantine LC-MS method was developed in perfusate and mouse brain homogenate.
- An in situ transcardiac perfusion mouse model was validated in our laboratory.
- Application of the methods demonstrated reduced brain uptake of memantine in a mouse model of Alzheimer's disease.